Editorial Policies

Aims and Scope

The journal was intended to be an interdisciplinary scientific publication focusing attention on innovative ontogenetic projects in Hematology, Immunology and Oncology. Cellular regulation in a developing organism of a child and genetic or acquired regulation impairments are the basis for contemporary understanding of human disorders. This journal knows no equals in Russia and other countries. The aim of the journal is to promote exchange of scientific experience related to the control of proliferation, differentiation, cell-cell interaction, autoinflammation, apoptosis of hematopoietic and immunogenic cells and the use of this knowledge for clinical purposes: treatment of children, adolescents and young adults. The target audience: pediatricians, neonatal specialists, hematologists, oncologists, geneticists, molecular biologists, experts in hematopoietic stem cell transplantation and cell technologies as well as specialists in 28 related clinical areas.

 
 

Peer Review Process

All submitted manuscripts undergo compulsory peer review in the course of 4-6 weeks since a manuscript registration at the Editorial Office.

As a rule, permanent members of the Editorial Board and/or Advisory Editors act as reviewers of scientific articles, but specialists renowned for their works in one of the areas of Medicine can be engaged as well, in accordance with the target area of scientific papers.

A reviewer for the evaluation of a submitted article is chosen by the Editor-in-Chief or their deputies.

Manuscripts (without authors’ surnames and institutional affiliation (where the work has been carried out)) are sent to reviewers together with an official letter from the Editorial Team.

In case of a negative review, a motivated refusal is sent to the author within 10 (ten) days as of the receipt of the review. For ethical reasons, the reviewer’s surname is not disclosed.

If a revision of the article is needed (introduction of amendments or supplements), the authors are sent a relevant letter requesting for the necessary revision to be made within 1-2 months (max. within 3 months as of the date of sending the review). Thereafter the authors should send the revised article back for the second review (to the reviewer who made comments requiring revision).

If authors refuse to revise the manuscript, they should inform the Editorial Team about their refusal to publish the article. If authors do not send the revised version of the article back within 3 months as of the date of sending the review, the manuscript is removed from the database by the Editorial Team.

An appropriate notification of the removal of a manuscript from the database due to the expiration of time allocated for revision is sent to authors. The sent manuscripts are not to be returned.

In case authors disagree with a reviewer’s opinion, the Editorial team may decide by authors' request to send the article to another reviewer or several reviewers for the second review in order to get an impartial expert opinion. In such situations, an article and reviews on it are to be discussed at the meeting of the Editorial Board. The collective decision taken by the Editorial Board is to be brought to the notice of the authors of the article within 10 (ten) working days starting from the date of the Editorial Board meeting.

In case of a repeated negative review (after all flaws mentioned in the first review have been corrected), it can be suggested that the authors should revise the article once again. This procedure should take no more than 2 months, whereafter the revised article is subject to a new review. After the third negative review, the article is not subject to any further reviews, and a rejection slip is sent to the authors within 10 (ten) working days as of the receipt of the third negative review.

Materials for such columns as “Jubilees” and “Obituaries” as well as informationmessages or reports are not subject to review (only academic editing is required).

Reviews are archived in the Editorial Office for a period of 5 (five) years. The copies of the reviews can be sent to authors at their request.

The Editorial Team is obliged to send the copies of reviews upon the request of the Ministry of Education and Science of the Russian Federation.

Articles with favorable review reports and the approval of the Editorial Board are published in the upcoming journal issues (as a rule, within 2 – 4 months), whereof authors are immediately notified by an editor.

 

Publication Frequency

Four issue per year (quarterly)

 

Open Access Policy

"Pediatric Hematology/Oncology and Immunopathology" is an open access journal. All articles are made freely available to readers immediatly upon publication.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. 

The Publisher grants usage rights to others using an open license (Creative Commons Attribution 4.0 International) allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose.

For more information please read BOAI statement.

 

 

 

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

 

Indexation

Articles in "Pediatric Hematology/Oncology and Immunopathology" are indexed by several systems:

  • Russian Scientific Citation Index (RSCI) – a database, accumulating information on papers by Russian scientists, published in native and foreign titles. The RSCI project is under development since 2005 by “Electronic Scientific Library” foundation (elibrary.ru).
  • Google Scholar is a freely accessible web search engine that indexes the full text of scholarly literature across an array of publishing formats and disciplines. The Google Scholar index includes most peer-reviewed online journals of Europe and America's largest scholarly publishers, plus scholarly books and other non-peer reviewed journals.
  • EDS
  • NLM Catalog
  • Scopus
  • VINITI RAS
  • Lens
  • Research4life

 

Publishing Ethics

All parties involved in the act of publishing (i.e. the author, the editorial staff, the peer reviewer and the publisher of the journal) must follow the standards of ethical behavior specified in this Policy. Our ethics statements are based on COPE’s Best Practice Guidelines for Journal Editors.

Duties of Editor and (or) Publisher

Publication Decisions

The Editorial Team is responsible for deciding which of the articles submitted to the journal should be published. The Editorial Team is guided by the policy of the journal and constrained by legal requirements related to libel, insult, copyright infringement and plagiarism. Members of the Editorial Board will confer with reviewers in making this decision.

Fair Play

The Editorial Team shall evaluate manuscripts for their intellectual content without regard to race, gender, citizenship, ethnic origin, occupation, place of work and residence, political, philosophical, religious or other beliefs of authors.

Confidentiality

The Editorial Team must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, members of the Editorial Board, the Advisory Editors and the publisher.

Disclosure and Conflicts of Interest

Members of the Editorial Board and the Advisory Editors must not use unpublished materials disclosed in a submitted manuscript in their own research without the written consent of the author. Editors and peer reviewers should recuse themselves from considering a manuscript if they are in any kind of competitive relationship with an author, or a company connected to the manuscript, or if any other conflict of interests exists. Editors must require all parties involved in the act of publishing to disclose any conflict(s) of interest.

Complaints of Author Unethical Behavior

The Editorial Team is obliged to take appropriate and reasonable measures with regard to complaints arising from unethical behavior of an author. In case the complaint has been confirmed by appropriate facts, the Editorial Team can reject publication of the article, cease further cooperation with the author, publish a disclaimer, or prevent further unethical behaviour of the author by some other means.

Duties of Reviewers

Contribution to Editorial Decisions

Peer review assists editors in making editorial decisions and may also serve the author in improving the paper.

Promptness

Reviewers are oblidged to provide the report within the period specified by editors. Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality

Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor-in-chief.

Standards of Objectivity

Reviewers should conduct the review process objectively and should not address any personal criticism to authors. Reviewers should also express their views clearly with supporting arguments.

Acknowledgement of Sources

Reviewers must ensure that authors have acknowledged all scientific and other sources of information that they used in their research. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. Reviewers should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest

Reviewers may not use material from unpublished manuscripts in their own interest. Reviewers are obliged to decline to review a manuscript in presence of any type of conflict of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors or institutions connected to the manuscript.

Author Responsibilities

Manuscript Preparation for Publication

Authors of original research articles should present accurate data used in the course of research work performed as well as an objective discussion of its significance. An article should contain necessary essential data and literature references to permit others to replicate the work. Fraudulent or knowingly false statements constitute unethical behavior and are unacceptable.

Raw Data Access and Retention

Authors must be able to provide raw research data upon editorial request, and should be prepared to provide public access to such data. Authors should retain such data for a reasonable time after publication.

Originality and Plagiarism

Authors should submit entirely original articles. If the author has used the work and/or included in their article some pieces of works (citations) of others, this should be appropriately cited or quoted (quotation marks, citation reference).

Multiple or Concurrent Publication

The author should not submit the manuscript of a previously published article. The author should not submit the same manuscript to more than one journal at the same time. Submitting a manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable.

Acknowledgement of Sources

Authors should properly acknowledge all scientific or other sources of information that they used in their research and that had a significant influence on its results.

Authorship and Co-authorship of Manuscripts

Authorship should be limited to those who have made a significant contribution to the results of the reported study (the conception, design and execution of the study, the interpretation of the study results). All those who have made significant contributions should be listed as co-authors. Where there are others who have made less significant contribution or participated in certain technical aspects of the research project, they should be mentioned in the acknowledgement section. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper.

Author Disclosure of Conflict of Interest

All authors should disclose any financial or other conflicts of interest that might be construed to influence the review and interpretation of their manuscript. All sources of financial support for the project should be disclosed and stated in a manuscript.

Correction of Errors in Published Works

When the author discovers a significant error or inaccuracy in his/her published work, it is the author’s obligation to promptly notify the Editorial Team and cooperate with the editors to correct the error. If the Editorial Team becomes aware of an error from a third party, the author must promptly correct the error or offer the proof of its absence.

Statement of Human and Animal Rights and Statement of Informed Consent

If the work involves the use of animal or human subjects, the authors should ensure that the manuscript contains a statement that all research stages were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committees have approved them. In a manuscript, it should be clearly stated that informed consent has been obtained from all human subjects involved in the research.

 

Founder

FSBI “D. Rogachev NMRCPHOI” of Ministry of Healthcare of the Russian Federation, “Doctors, Innovations, Science for Children” Foundation

 

Author fees

Publication in “Pediatric Hematology/Oncology and Immunopathology" is free of charge for all the authors.

The journal doesn't have any Arcticle processing charges.

The journal doesn't have any Article submission charges.

 

Disclosure and Conflict of Interest

Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

 

Plagiarism detection

“Pediatric Hematology/Oncology and Immunopathology" use native russian-language plagiarism detection software Antiplagiat to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.

 

Preprint and postprint Policy

Prior to acceptance and publication in “Pediatric Hematology/Oncology and Immunopathology", authors may make their submissions available as preprints on personal or public websites.

As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in “Pediatric Hematology/Oncology and Immunopathology" we suggest that the link to the article on journal's website is used when the article is shared on personal or public websites.

Glossary (by SHERPA)

Preprint - In the context of Open Access, a preprint is a draft of an academic article or other publication before it has been submitted for peer-review or other quality assurance procedure as part of the publication process. Preprints cover initial and successive drafts of articles, working papers or draft conference papers.
 
Postprint - The final version of an academic article or other publication - after it has been peer-reviewed and revised into its final form by the author. As a general term this covers both the author's final version and the version as published, with formatting and copy-editing changes in place.